| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 01/19/1995 | CA2166222A1 Heme binding compounds and use thereof |
| 01/19/1995 | CA2165778A1 Growth differentiation factor-7 |
| 01/19/1995 | CA2164960A1 Novel (1-phenyl-1-heterocyclyl)methanol and (1-phenyl-1-heterocyclyl)methylamine derivatives |
| 01/19/1995 | CA2164876A1 Novel (1-phenyl-1-heterocyclyl) alkane derivatives and their use as neuroprotective agents |
| 01/19/1995 | CA2164856A1 Novel (1-heteroazolyl-1-heterocyclyl) alkane derivatives and their use as neuroprotective agents |
| 01/19/1995 | CA2163994A1 Piperidinyl substituted methanoanthracenes as d1/d2-antagonists and 5ht2-serotanin-antagonists |
| 01/18/1995 | EP0634411A1 Process for the preparation of 8-(4'C4"-(pyrimidin-2'''-yl)-piperazin-1''-yl)-butyl)-8-aza-spiro(4,5)decan-7,9-dione and of its hydrochlorides of high purity |
| 01/18/1995 | EP0634396A1 Amino acid derivatives and their use as inhibitors of encephalinase |
| 01/18/1995 | EP0633886A1 Pharmaceutically active bicyclic-heterocyclic amines |
| 01/18/1995 | EP0633885A1 Triazoloquinoxalin-1,4-diones and their preparation and use |
| 01/18/1995 | EP0633882A1 4- 4'-piperidinyl or 3'-pirrolidinyl] substituted imidazoles as h3-receptor antagonists and therapeutic uses thereof |
| 01/18/1995 | EP0633879A1 Enantiomeric 1-phenyl-2-(2-pyridinyl)ethylamine for the treatment of neurodegenerative disorders |
| 01/18/1995 | EP0633779A1 USE OF $g(b)-CARBOLINES |
| 01/18/1995 | EP0284621B1 New psychostimulant agent |
| 01/17/1995 | US5382669 Process for the preparation of ergoline derivatives |
| 01/17/1995 | US5382601 Memantine-containing solid pharmaceutical dosage forms having an extended two-stage release profile and production thereof |
| 01/17/1995 | US5382596 Substituted 2-aminotetralins |
| 01/17/1995 | US5382594 Cognition activators |
| 01/17/1995 | US5382593 Antioxidants or anticoagulants |
| 01/17/1995 | US5382592 Antimigraine cyclobutenedione derivatives of tryptamines |
| 01/17/1995 | US5382591 Antipyretic and analgesic methods using optically pure R-ketorolac |
| 01/17/1995 | US5382586 Tranquilizers |
| 01/17/1995 | US5382584 Adenosine re-uptake inhibiting derivatives of diphenyl oxazoles, thiazoles and imidazoles |
| 01/17/1995 | US5382578 Methods for treating convulsions and ischemia with substituted dibenzoxazepine compounds |
| 01/17/1995 | US5382569 Hexapeptides for cardiovascular disorders |
| 01/17/1995 | CA2128164A1 Process for the preparation of high purity buspiron and the hydrochloride thereof |
| 01/17/1995 | CA1334004C Essential fatty acid compositions |
| 01/17/1995 | CA1334001C Stable pharmaceutical composition containing esmolol |
| 01/12/1995 | WO1995001429A1 Pharmaceutical compositions and their use, namely for the treatment of neurodegenerative diseases |
| 01/12/1995 | WO1995001354A1 Pharmacologically active enantiomers |
| 01/12/1995 | WO1995001353A1 Antihypertensive tricyclic azepine derivatives useful as inhibitors of enkephalinase and ace |
| 01/12/1995 | WO1995001351A1 Substituted arylthioalkylthiopyridines |
| 01/12/1995 | WO1995001333A1 Acetamide derivatives and their use for modifying feeding behaviour modifiers |
| 01/12/1995 | WO1995001169A1 Neurotropic agent and process for producing it |
| 01/12/1995 | WO1995001096A1 Pharmaceutical compositions and use thereof for treatment of neurological diseases and etiologically related symptomology |
| 01/12/1995 | CA2166477A1 Neurotropic agent and process for producing it |
| 01/12/1995 | CA2166383A1 Pharmaceutical compositions and use thereof for treatment of neurological diseases and etiologically related symptomology |
| 01/12/1995 | CA2166327A1 Substituted arylthioalkylthiopyridines |
| 01/12/1995 | CA2166128A1 Acetamide derivatives and their use for modifying feeding behaviour modifiers |
| 01/11/1995 | EP0633261A1 Quinoline-3-acetic acid derivative, process for producing the same, and use thereof |
| 01/11/1995 | EP0633260A1 2,3-Dihydro-1,4-benzodioxin-5-yl-piperazine derivatives having 5-HT1A-antagonistic activity |
| 01/11/1995 | EP0633259A1 Sulfonylaminopyrimidines, their preparation and their use as medicine |
| 01/11/1995 | EP0633251A1 Derivatives of 9-aminoacridine having psychotropic, antiamnestic and lipid regulating properties |
| 01/11/1995 | EP0632829A1 Thrombin receptor antagonists |
| 01/11/1995 | EP0632809A1 Quinuclidine derivatives as substance p antagonists |
| 01/11/1995 | CN1027369C Excitatory amino acid antagonists |
| 01/10/1995 | US5380937 Derivatives of 4-hydroxybutyric acid |
| 01/10/1995 | US5380878 Racemization, cognition activator |
| 01/10/1995 | US5380847 Synthesis of certain 1-(1-methylpiperidin-4-y1)-3-phenylpyrazolo[4,3-C]pyridines |
| 01/10/1995 | US5380750 Arylethylamine compounds |
| 01/10/1995 | US5380742 4H-thieno[3,4-c]pyrrole derivatives |
| 01/10/1995 | US5380736 Cholecystokinin and gastric antagonist |
| 01/10/1995 | US5380729 12-hetero substituted 6,11-ethano-6,11-dihydrobenzo (b) quinolizinium salts and compositions and method of use thereof |
| 01/10/1995 | US5380714 2-furyl-triazalo [1,5-a]-[1,3,5]triazines and pyrazolo [2,3-a][1,3,5]triazines |
| 01/05/1995 | WO1995000848A1 Compositions and methods for anti-addictive narcotic analgesis acivity screening and treatments |
| 01/05/1995 | WO1995000516A1 Novel chemical compounds having pde-iv inhibition activity |
| 01/05/1995 | WO1995000510A1 Processes and intermediates for the preparation of 5-[2-(4-(benzoisothiazol-3-yl)-piperazin-1-yl)ethyl]-6-chloro-1,3-dihydro-indol-2-one |
| 01/05/1995 | WO1995000501A2 Phenyl heterocycles as cyclooxygenase-2 inhibitors |
| 01/05/1995 | WO1995000489A1 Isoquinoline derivatives as therapeutic agents |
| 01/05/1995 | WO1995000486A1 N-substituted azaheterocyclic carboxylic acids and esters thereof |
| 01/05/1995 | WO1995000485A1 N-substituted azaheterocyclic carboxylic acids and esters thereof |
| 01/05/1995 | WO1995000484A1 N-substituted azaheterocyclic carboxylic acids and esters thereof |
| 01/05/1995 | WO1995000483A1 N-substituted azaheterocyclic carboxylic acids and esters thereof |
| 01/05/1995 | WO1995000477A1 Nitrato amino acid disulphides for use in the therapy of disorders of the cardiovasculary system |
| 01/05/1995 | WO1995000472A1 1,2 diacylated hydrazine derivatives and their use as all adhesion inhibitors |
| 01/05/1995 | WO1995000148A1 Use of ropivacaine in the manufacture of a pharmaceutical with analgetic effect with minimal motor blockade |
| 01/05/1995 | WO1995000145A1 Utilization of efaroxan and derivatives thereof for the preparation of a medicament intended to the treatment of parkinson disease |
| 01/05/1995 | WO1995000135A1 Medical treatment using thyroid hormones |
| 01/05/1995 | WO1995000132A1 Use of modafinil for the treatment of sleep apnoea and ventilation problems of central origin |
| 01/05/1995 | WO1994026263A3 Use of a transition metal complex for the treatment of septic shock |
| 01/05/1995 | WO1994022445A3 Pharmaceutical compositions for intranasal administration of dihydroergotamine, apomorphine and morphine |
| 01/05/1995 | CA2364039A1 Use of phenyl heterocycles in the relief or treatment of rheumatoid arthritis, osteoarthritis, fever, pain, headache or dysmenorrhea |
| 01/05/1995 | CA2165950A1 N-substituted azaheterocyclic carboxylic acids and esters thereof |
| 01/05/1995 | CA2165948A1 N-substituted azaheterocyclic carboxylic acids and esters thereof |
| 01/05/1995 | CA2165947A1 N-substituted azaheterocyclic carboxylic acids and esters thereof |
| 01/05/1995 | CA2165946A1 N-substituted azaheterocyclic carboxylic acids and esters thereof |
| 01/05/1995 | CA2165823A1 Isoquinoline derivatives as therapeutic agents |
| 01/05/1995 | CA2165822A1 The medical treatment using thyroid hormones |
| 01/05/1995 | CA2165437A1 Utilization of efaroxan and derivatives therof for the preparation of a medicament intended to the treatment of parkinson disease |
| 01/05/1995 | CA2164966A1 Compositions and methods for anti-addictive narcotic analgesis activity screening and treatments |
| 01/05/1995 | CA2163888A1 Phenyl heterocycles as cyclooxygenase-2 inhibitors |
| 01/04/1995 | EP0632129A1 Recombinant foamy virus vectors for medicinal and diagnostic uses, and processes for preparing recombinant foamy virus vectors |
| 01/04/1995 | EP0632035A1 Aminoalkylchomones, process for their preparation and pharmaceutical compositions containing them |
| 01/04/1995 | EP0632016A1 1,2-Diacylated hydrazine derivatives and their use as cell adhesion inhibitors |
| 01/04/1995 | EP0632008A1 Pentanoic acid derivatives |
| 01/04/1995 | EP0631781A1 Opioid formulations having extended controlled release |
| 01/04/1995 | EP0631623A1 Dna encoding taurine and gaba transporters and uses thereof |
| 01/04/1995 | EP0631580A1 PYRIDO 2,3-d]PYRIMIDINE DERIVATIVES AS PHOSPHODIESTERASE INHIBITORS |
| 01/04/1995 | EP0631503A1 Use of vasoactive intestinal peptide (vip) to induce temporary paralysis of the gastrointestinal tract |
| 01/04/1995 | EP0536173B1 Pyridopyrazine derivatives for treating substance abuse and addiction |
| 01/04/1995 | CN1097006A O-aryl ethers of morphinans |
| 01/03/1995 | US5378848 Benzodiazepine agonist, psychotropic, antianxiety, cerebral function activator, anesthesia atagonist |
| 01/03/1995 | US5378729 Diamide derivatives |
| 01/03/1995 | US5378723 Cholinergic agonist and blocking agents |
| 01/03/1995 | US5378451 Topical medicinal pressurized aerosol compositions and method of preparation, method of use and article of manufacture thereof |
| 12/28/1994 | EP0630893A1 N,n'-disubstituted amide derivative |
| 12/28/1994 | EP0630648A1 Use of acyl L-carnitine gamma-hydroxybutyrate for the treatment of drug addiction |
| 12/28/1994 | EP0630646A1 Controlled-release formulations coated with aqueous dispersions of ethylcellulose |
| 12/28/1994 | EP0630376A1 Condensed indole derivatives as 5ht 4?-receptor antagonists |
| 12/28/1994 | EP0630375A1 Biologically active tropane derivatives |